Navigation Links
Sepramesh Biosurgical Composite

ProductsSepramesh Biosurgical Composite
Company Genzyme Biosurgery
Item Sepramesh Biosurgical Composite
Features 
  • Designed for the repair of abdominal hernias
  • It consists of a PPM mesh that has two distinct sides: one is coated with a layer of sodium hyaluronate and carboxymethylcellulose and the other side is uncoated
  • The composite design encourages complete tissue incorporation (repair strength) on the hernial defect while minimizing tissue attachment to the mesh
    • Description Sepramesh Biosurgical Composite is designed for the repair of abdominal hernias. It consists of a PPM mesh that has two distinct sides. One side of the mesh is coated with a layer of sodium hyaluronate and carboxymethylcellulose (similar to Genzyme Biosurgery's Seprafilm® Adhesion Barrier). This coated side is bioresorbable, providing a temporary physical barrier that separates the underlying tissue and organ surfaces from the mesh. The other side of the mesh is uncoated, allowing for complete tissue ingrowth similar to bare PPM mesh. Shortly after placement of Sepramesh, the coated side of the mesh becomes a hydrated gel that is slowly resorbed into the body within one week. The bioresorbable barrier separates the mesh from underlying organs while a protective cell layer forms over the mesh. The composite design encourages complete tissue incorporation (repair strength) on the hernial defect while minimizing tissue attachment to the mesh.
    Info Genzyme Biosurgery
    Customer Service: (888) 379-6847
    Web site: http://www.genzymebiosurgery.com/

    Related medicine products :

    1. Composite Tabletop For An Urological Imaging System
    ...es its name from its first known site of origin, t... bound to anti-chymotrypsin (PSA-ACT) and other co... in patients with prostate cancer, benign prostati...tion, PSA serum levels appear to correlate with th...
    Increase profitability by reducing chair time with simple test,sequences that can be administered by ancillary office staff in,less than 5 minutes. New Unsurpassed Homogenous Illumination.,Back
    Contrast Sensitivity is Recognized as a Valuable Tool for Measuring Functional Vision Loss Caused by Early Eye Disease. Near Test F.A.C.T. 101: Size 5 in x 7 in (12.7cm x 17.78cm) Can be Hand-Held or
    Adult: Letter Monocular Acuity, Binocular Astigmatism, Acuity Balance, Supression, Binocular Acuity, Fixation Desparity, Muscle Balance, Stereopsis
    Medicine Products:
    (Date:12/2/2008)...wire/ -- A scientist who helped,explain how our b...ormation we,see has won the 2009 University of L...nne Treisman, the James S. McDonnell Distinguished... University , was selected for the ninth Grawemeye... Treisman, a cognitive psychologist, proposed...
    (Date:12/2/2008)...sity, The Brigham and Women,s Hospital (Boston), H...s found a new drug with the potential to alleviate... , Dr Shantha Rajaratnam from Monash University...cal Medicine said tasimelteon, a drug which acts o...hly effective treatment for circadian rhythm sleep...
    (Date:12/2/2008)...h risk, data review finds , , TUESDAY, D...doubt on the safety of the drug Trasylol (aprotini...surgery. , Trasylol is already the subject of c...ved from the market in 2007. , In the new study...dings from 49 randomized clinical trials. They con...
    (Date:12/2/2008)...ire/ -- Seniors, disabled,Michiganders, state HMO...,oppose efforts by Blue Cross to jam anti-consume...k session of the Legislature. , "This could...chigan," said,RoAnne Chaney, Health Policy Manage...A vote for this bill is a vote to dramatically rai...
    Breaking Medicine News(10 mins):Health News:Theory of How Brain Builds Images Earns Grawemeyer Prize 2Health News:New medication brings hope of jet lag cure 2Health News:Another Study Warns of Risk From Cardiac Surgery Drug 2Health News:Opposition Continues to Grow to Blues' Legislation 2Health News:Opposition Continues to Grow to Blues' Legislation 3
    ...al was removed and the name was shortened as Calga...eel that the content and presentation// continue t...ealize they were just trying to be light-hearted a... mental illness who have to face the stigma found ...
    ...By recognizing sugars, a technique developed by Un...akansson sets the stage// for new cancer diagnosis...e points to assemblies of sugars called glycans at...faces as accomplices in the growth and spread of t...
    ...nds that stents do not prevent heart attacks as co...nimize chest pains and to prevent heart attacks//.... blocked arteries to keep them open. This landmar...of Veterans Affairs, confirms that stents do impro...
    ...nds that approximately 20% of children with Acute ...apse of their disease following treatment//. Of th...y shown that these relapses were due to small numb... the treatment administered to the patient," said ...
    Other Medicine News:Health News:A Sweet Step Toward New Cancer Therapies 2Health News:Stents Do Little to Prevent Heart Attacks 2
    (Date:12/1/2008)...ated With ENB-0040 at Children,s Hospital, Health ...ec. 1 Enobia Pharma, an emerging C...l therapeutics for serious bone disorders, today a...ical program for hypophosphatasia was dosed. Enobi...) with ENB-0040 for the treatment of this rare and...
    (Date:12/1/2008)...policy , , ROCHESTER, Minn., Dec. 1 /PRNew...finds the use of the drug therapy etanercept ineff...nflammation of the liver caused by excessive consu...blished in the December issue of Gastroenterology...IDEO ALERT: Additional audio and video resources, ...
    (Date:12/1/2008)... Following a,Request for...e an MVA-based,third generation smallpox vaccine... behalf of the Canadian Department of National Def...or the delivery of IMVAMUNE(R). , The Canad...of the,country,s bio-preparedness programme. , ...
    (Date:12/1/2008)...ll/ -- GeoVax Labs, Inc.,(OTC Bulletin Board: GOV...ing,human vaccines for diseases caused by HIV-1 (...s agents, announced today that the launch of its P...welve sites across North and South America.,These...tional Institutes of,Health (NIH), and the HIV Va...
    Breaking Medicine Technology:Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Consumer Reports Poll 3A Americans Demand Health Reform But Are Unsure About How to Achieve it 11025 1Consumer Reports Poll 3A Americans Demand Health Reform But Are Unsure About How to Achieve it 11025 2Consumer Reports Poll 3A Americans Demand Health Reform But Are Unsure About How to Achieve it 11025 3Consumer Reports Poll 3A Americans Demand Health Reform But Are Unsure About How to Achieve it 11025 4Halogen Receives High Ratings from Bersin 26 Associates Company recognized as a market leader and receives praise for outstanding customer satisfa 3031 1Halogen Receives High Ratings from Bersin 26 Associates Company recognized as a market leader and receives praise for outstanding customer satisfa 3031 2Stevens researchers provide oversight for three year mariculture program in Egypt and Israel 2118 1West Pharmaceutical Services to Present at the 2008 UBS Global Healthcare Services Conference 11019 1West Pharmaceutical Services to Present at the 2008 UBS Global Healthcare Services Conference 11019 2
    ...AGO, June 04, 2007 /PRNewswire/ -- GlaxoSmithKline...dies of pazopanib in,advanced or metastatic renal ...ue sarcoma (STS). These trials were presented at t...Clinical Oncology,(ASCO) in Chicago. The results o...ther investigations. , Pazopanib is an oral, inves...
    ...LAND--(BUSINESS WIRE)--Jun 4, 2007 - Copernicus Th...eam at University of Oklahoma,Health Sciences Cent...gy, demonstrated that Copernicus, DNA nanoparticle...initis pigmentosa (RP). These,findings were presen...g in Seattle, WA. Mutations in genes important in ...
    Other Medicine Technology:GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 2GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 3GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 4GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 5GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 6GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 7Vision Deficit in Retinitis Pigmentosa Mice Corrected with DNA,Nanoparticles 2